Privium Fund Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$867K Buy
242,146
+72,000
+42% +$286K 0.18% 46
2025
Q4
$597K Sell
170,146
-262,614
-61% -$899K 0.11% 48
2025
Q3
$1.41M Hold
432,760
0.25% 36
2025
Q2
$1.12M Hold
432,760
0.24% 30
2025
Q1
$2.89M Buy
432,760
+35,110
+9% +$347K 0.75% 21
2024
Q4
$5M Buy
397,650
+102,850
+35% +$1.55M 1.13% 19
2024
Q3
$5.44M Buy
294,800
+43,820
+17% +$898K 1.35% 21
2024
Q2
$4.96M Buy
250,980
+15,930
+7% +$366K 1.27% 23
2024
Q1
$6.33M Buy
235,050
+2,000
+0.9% +$56.8K 1.69% 18
2023
Q4
$6.87M Buy
233,050
+89,700
+63% +$1.98M 1.92% 16
2023
Q3
$2.94M Buy
143,350
+84,000
+142% +$1.53M 0.87% 29
2023
Q2
$1.19M Hold
59,350
0.34% 44
2023
Q1
$1.02M Hold
59,350
0.34% 39
2022
Q4
$1.16M Buy
59,350
+9,600
+19% +$177K 0.44% 33
2022
Q3
$698K Buy
49,750
+25,000
+101% +$390K 0.26% 53
2022
Q2
$341K Buy
+24,750
New +$295K 0.12% 73

Other funds holding RCKT